Restrict use of pain reliever Tapentadol: Child rights panel urges government

“The chairperson, NCPCR recommended to examine the issue to notify the drug under Schedule H 1 of Drugs and Cosmetics Rules, 1945,” another official said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news